{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:39:59Z","timestamp":1773293999502,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.arcped.2009.02.019","type":"journal-article","created":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T10:15:04Z","timestamp":1247048104000},"page":"1208-1212","source":"Crossref","is-referenced-by-count":2,"title":["Traitement psychotrope \u00e0 long terme dans les d\u00e9pressions de l\u2019enfant"],"prefix":"10.1016","volume":"16","author":[{"given":"H.","family":"Denizot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Laporte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-M.","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2009.02.019_bib1","unstructured":"Expertise collective Inserm. Troubles mentaux. D\u00e9pistage et pr\u00e9vention chez l\u2019enfant et l\u2019adolescent. Paris: Ed. Inserm; 2003."},{"key":"10.1016\/j.arcped.2009.02.019_bib2","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/chi.0b013e318145ae1c","article-title":"Practice parameter for the assessment and treatment of children and adolescents with depressive disorders","volume":"46","author":"Birmaher","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.arcped.2009.02.019_bib3","unstructured":"US Food and Drug Administration. Labeling change request letter for antidepressant medications. Donn\u00e9es disponibles sur http:\/\/ww.fda.gov\/CDER\/drug\/antidepressants\/SSRIlabelChange.htm. 2004\u00a0October."},{"key":"10.1016\/j.arcped.2009.02.019_bib4","unstructured":"Afssaps. Mise au point\u00a0: le bon usage des antid\u00e9presseurs chez l\u2019enfant et l\u2019adolescent. www.afssaps.sante.fr. Donn\u00e9es consult\u00e9es en janvier\u00a02008."},{"key":"10.1016\/j.arcped.2009.02.019_bib5","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/archpsyc.1987.01800220016003","article-title":"The clinical picture of major depression in children and adolescents","volume":"44","author":"Ryan","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.arcped.2009.02.019_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archpsyc.1991.01810330075011","article-title":"Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence","volume":"48","author":"Frank","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.arcped.2009.02.019_bib7","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.297.15.1683","article-title":"Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials","volume":"297","author":"Bridge","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.arcped.2009.02.019_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002317","article-title":"Tricyclic drugs for depression in children and adolescents","volume":"2","author":"Hazell","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2009.02.019_bib9","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/01.chi.0000140453.89323.57","article-title":"Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study","volume":"43","author":"Emslie","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.arcped.2009.02.019_bib10","first-page":"757","article-title":"Les antid\u00e9presseurs favorisent-ils la suicidalit\u00e9 et le suicide chez les individus d\u00e9pressifs\u00a0?","volume":"7","author":"H\u00e4ttenensschwiler","year":"2007","journal-title":"Forum Med Suisse"},{"key":"10.1016\/j.arcped.2009.02.019_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1176\/appi.ajp.2007.07010205","article-title":"Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs","volume":"165","author":"Morrato","year":"2008","journal-title":"Am J Psychiatry"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X09000979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X09000979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T14:22:46Z","timestamp":1545142966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X09000979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0929693X09000979"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2009.02.019","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}